Stent Thrombosis Teaching Module: Timing, Mechanism and Bail-Out

Module orientation

This teaching module sits in the interventional strand of the programme and is written for cardiology registrars, DM and DNB candidates in their exit year, and interventional fellows who already scrub for coronary work. It assumes you can describe a stent platform and a P2Y12 inhibitor without prompting. What it drills instead is the reflex that separates a competent operator from a hesitant one: when a patient re-presents with a stented vessel, the interval since implantation should already have narrowed your differential before the wire crosses the lesion. We teach the topic as a single decision tree hung off a clock.

Learning objectives

• State the three Academic Research Consortium certainty tiers without paraphrase, and place a borderline unexplained death in the correct tier.
• Convert an interval since implantation into a ranked mechanistic differential, and justify the ranking to an examiner.
• Specify what an intravascular imaging pullback must demonstrate before you accept a mechanical cause as excluded.
• Select an intraprocedural antithrombotic strategy when oral absorption cannot be relied upon.
• Construct a discharge antithrombotic plan for a patient whose event occurred while adherent to therapy.

Block 1 — The case that opens the session

We begin every delivery of this module with the same tracing. A 61-year-old man, stented to the mid left anterior descending eleven days earlier for a non-ST-elevation presentation, arrives with crushing pain and anterior ST elevation. He stopped his clopidogrel four days ago because a dentist asked him to. The room usually reaches the right answer quickly. The instructive part is what the room does not say: nobody asks whether the original result was mechanically sound, and nobody asks what the post-dilatation balloon was.

That omission is the teaching point. Interruption of therapy is a permissive factor, not a complete explanation; a well-expanded, well-apposed stent tolerates a brief antiplatelet gap far better than an under-expanded one. We therefore insist that trainees state two contributors for every event — one pharmacological, one structural — even when the first is obvious.

Block 2 — The certainty language

Marks and, more importantly, registry validity depend on using the ARC vocabulary precisely. Definite events require visual proof: thrombus seen angiographically within or adjacent to the stented segment in the presence of an acute ischaemic syndrome, or pathological confirmation. Probable events cover unexplained death within the first thirty days after implantation, and any infarction in the distribution of the stented vessel where angiographic confirmation was never obtained. Possible events are unexplained deaths occurring after that thirty-day boundary.

The error we see most often in written papers is misfiling a death at around three weeks as possible. The thirty-day line separates probable from possible; it has nothing to do with the definite tier, which is defined by evidence rather than by timing. We rehearse this with rapid-fire vignettes until the classification is automatic, an approach mirrored across the written papers in our cardiology board review mastery course text.

Block 3 — Reading mechanism from the clock

The single highest-value construct in this module is a two-column mapping between interval and dominant mechanism. Learn it and most vignettes resolve without further reasoning.

Two epidemiological points reverse trainee intuition. With contemporary drug-eluting platforms the absolute event rate across all timings is low — on the order of half a percent of procedures. And when a cohort is followed for years, very late events accumulate to become the largest share of the total, not the acute ones, so candidates who assume the first day carries the greatest numerical burden answer prevalence questions incorrectly. Lethality is uniformly high whenever the event occurs; historical series place early mortality in the region of one in five, which is why this is a code activation rather than a ward review.

Block 4 — What the imaging run must answer

Imaging is taught here as an interrogation with a fixed question list. The pullback must answer: is the minimum stent area adequate; is there malapposition and over what length; is there edge dissection or an untreated disease shoulder; and is there neoatherosclerotic plaque rupture within the segment. Conventionally accepted adequacy thresholds are a minimum stent area of at least 5.0 mm² by intravascular ultrasound and at least 4.5 mm² by optical coherence tomography, adjusted upwards for large proximal vessels and downwards for genuinely small ones.

Calcium is the recurring culprit behind under-expansion, and the optical coherence tomography triad worth memorising is an arc of 180 degrees or more, a thickness of 0.5 mm or more, and a length exceeding 5 mm. A lesion carrying all three should have been modified before implantation rather than dilated harder afterwards. On the evidence side, ADAPT-DES linked intravascular ultrasound guidance with lower rates of definite or probable events at one year, and RENOVATE-COMPLEX-PCI showed benefit for imaging-guided intervention in complex anatomy. Current guidance favours intravascular imaging to guide percutaneous intervention in complex coronary lesions. Trainees wanting frame-by-frame interpretation work through our advanced PCI techniques course text alongside this block.

Block 5 — Pharmacology at the table

The pharmacology block is deliberately short and organised around absorption. A vomiting, intubated or shocked patient does not reliably absorb an oral loading dose, and the correct answer in that setting is intravenous P2Y12 blockade with cangrelor, which achieves near-immediate inhibition and washes out within about an hour of stopping. Glycoprotein IIb/IIIa inhibition remains a legitimate bail-out where thrombus burden is heavy and bleeding risk is acceptable. Procedural anticoagulation is unfractionated heparin titrated to an activated clotting time in the 250 to 300 second range, or bivalirudin.

Reloading the same agent that failed is the classic trap. A patient who thromboses while genuinely adherent to clopidogrel should be escalated to a potent agent rather than reloaded, and prasugrel or ticagrelor is preferred after acute coronary syndromes managed invasively. Where flow is restored mechanically but tissue perfusion remains poor, treat the microcirculation — the reasoning is developed fully in the companion cath lab complications course.

Block 6 — The morning-after decision

The last block moves from the table to the ward round. A patient who has had a stent thrombosis is, by definition, at high ischaemic risk, and duration decisions shift accordingly. The DAPT trial established that prolonged therapy reduces ischaemic events at the cost of bleeding; STOPDAPT-2 and SMART-CHOICE demonstrated that abbreviated therapy followed by P2Y12 monotherapy reduces bleeding without an obvious ischaemic penalty in selected populations; TWILIGHT extended that logic to high-risk patients after complex intervention. A prior event pushes almost every scoring instrument, including the DAPT score, towards extension, and formal bleeding assessment with PRECISE-DAPT or a HAS-BLED review should be documented rather than implied.

A short written reflection on why the index procedure failed is also required, since that document is what changes the next hundred cases. Material for the exercise draws on our reference on hidden and open catheterisation laboratory complications.

Self-check

• An unexplained death occurs on day 22 after implantation with no angiogram. Which tier? Probable — it falls inside the thirty-day window.
• Chest pain in recovery, ninety minutes after stenting a heavily calcified lesion. Leading mechanism? A mechanical one, most often under-expansion; go straight to imaging rather than reaching for a drug.
• The patient thromboses on day 9 while taking clopidogrel faithfully. Next antiplatelet step? Escalate to a potent P2Y12 inhibitor; do not reload clopidogrel.
• Which timing category accounts for the largest share of events across long-term follow-up? Very late events, not acute ones.
• Name the optical coherence tomography calcium features predicting under-expansion. Arc of 180 degrees or more, thickness of 0.5 mm or more, length beyond 5 mm.

How this module is taught in the course

The module runs as a ninety-minute session in the interventional pathway. It opens with the unfolding case above, moves through the timing-to-mechanism mapping using twelve archived angiograms, and closes with a live pullback review in which participants call the minimum stent area before the software measurement is revealed. Written reinforcement comes from the acute-care reading in the interventional and acute care course book collection, with a stem bank of forty vignettes released after the session. Candidates revising acute presentations more broadly usually pair it with our acute coronary syndromes course text. The original long-form reference article on acute stent thrombosis board review remains available for those who prefer a continuous prose treatment.

Module FAQ

Is this module suitable for a general cardiology candidate who does not intervene?

Yes. General papers examine classification, mechanism and antithrombotic escalation, all of which are covered here. The imaging block can be treated as background if you never operate.

How much prior interventional experience is assumed?

Enough to recognise a coronary angiogram and name the stented segment. Trainees who have not yet scrubbed usually take the module after completing the coronary anatomy and physiology sessions.

Does the module cover bioresorbable scaffolds?

Briefly, and mainly as a cautionary example: earlier-generation scaffolds carried a higher device thrombosis signal than contemporary everolimus-eluting stents, which is a favourite distractor in written papers.

What assessment follows the session?

A forty-stem written set and one recorded case presentation in which you must state two contributory mechanisms and defend your discharge antithrombotic plan.

Reviewed by Dr A M Thirugnanam, MD, MSICP, FSCAI, Ph.D., Senior Interventional Cardiologist — who teaches this module from archived cases in his own catheterisation laboratory in Hyderabad and revises the stem bank each academic year.